CLONZ is a biopharmaceutical firm promoted by a group of young and passionate Biotechnologists, focused on the development, manufacturing and commercialization of Human Therapeutic biosimilar Monoclonal Antibodies (MAbs).
Clonz got incorporated in 2009 and started its operations in September 2010 at Genome Valley, Hyderabad, India
With experienced team coming from recognized leaders in recombinant biosimilar manufacturing, Clonz is committed to delivering quality biologics to make treatment and care affordable to the world population in many disease indications, with special emphasis on Oncology.
DSIR (Govt.of India) Recognised R&D unit with fully integrated Mammalian platform to Develop Biosimilar MAbs
Company Details
- Employees
- 68
- Founded
- -
- Address
- Shamirpet, In
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- clonzbio.com
- Keywords
- MonoClonal Antibodies.
- HQ
- Shamirpet
Clonz Biotech Pvt Ltd Questions
Clonz Biotech Pvt Ltd's website is clonzbio.com
Clonz Biotech Pvt Ltd's LinkedIn profile is https://in.linkedin.com/company/clonz-bio
Clonz Biotech Pvt Ltd has
68 employees.
View email and phone details for 68
employees at Clonz Biotech Pvt Ltd.
Clonz Biotech Pvt Ltd's industry is
Biotechnology Research
Clonz Biotech Pvt Ltd's top competitors are
Sanzyme Biologics,
Unique Biotech,
Bharat Biotech,
Biological E. Limited,
Sanzyme,
Procell Biologics Pvt Ltd,
Yapan Bio,
Vivo Bio Tech Ltd.,
Enzene Biosciences Ltd,
Genesys Biologics.
Clonz Biotech Pvt Ltd's categories are Biotechnology Research
Clonz Biotech Pvt Ltd's founding year is 2009
